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ABSTRACT
The attempted formation of co-crystals with a series of cyclotriphosphazene derivatives has been investigated. Despite numerous
attempts, only one co-crystal was obtained. The crystal structure of this material, [hexakis(4-pyridyloxy)-cyclotriphos-
phazene][terephthalic acid]2.5, is presented here. The crystal structures of 2,2-bis(4-formylphenoxy)-4,4,6,6-bis[spiro(2’,2”-dioxy-
1’,1”-biphenylyl]cyclo-triphosphazene and hexakis(4-cyanophenoxy)cyclotriphosphazene are also reported for the first time.
The extremely low rate of co-crystal occurrence in these materials cannot be explained, despite the consideration of several possi-
bilities. This serves as a cautionary tale – co-crystal formation is not necessarily straightforward.
KEYWORDS
Cyclophosphazene, lack of co-crystal formation.
1. Introduction
Cyclophosphazenes, which are formally unsaturated com-
pounds containing alternating phosphorus-nitrogen bonds,1
have received much attention due to the wide range of possible
applications for these compounds.2 Cyclotriphosphazenes,
(R2PN)3, have received particular attention from the crystal
engineering community since the discovery of the remarkable
inclusion properties of tris(o-phenylenedioxy)cyclotriphos-
phazene (TPP).3 TPP is a highly robust host, forming inclusion
complexes in the solid state with a variety of solvents, whether it
is exposed to liquids or to solvent vapours.4 The high density,
nonporous structure of TPP has also been determined, and it has
been shown that under CO2 pressure the high density structure
can be transformed to the low density, porous structure.5 Not
only does this particular organic host include a wide variety of
small organic molecules, but it has also been shown to include
various polymers.6 We speculated that if TPP has the ability to
form such a broad range of inclusion compounds, the possibility
exists that other cyclotriphosphazene derivatives could also
form a range of interesting supramolecular assemblies – be they
inclusion compounds or co-crystals.7 It was therefore decided to
embark on a systematic investigation of co-crystal and solvate
formation with various cyclotriphosphazene derivatives.
Cyclotriphosphazenes are attractive targets for this kind of
systematic study due to the ease of synthesis of a variety of sub-
stituted derivatives from hexachlorocyclotriphosphazene,
(NPCl2)3.
2a,4c,8 Despite this, there have been few systematic crystal
engineering studies on cyclotriphosphazenes.9 Chandrasekhar
et al.9a used cyclotriphosphazenes and the principles of direc-
tional hydrogen bonding to design supramolecular assemblies
in the solid state. They specifically selected hydrazide deriva-
tives with the intent of using the terminal –NH2 groups as proton
donors and the phosphazene ring nitrogen atoms as proton
acceptors. This interaction results in the formation of a hexagonal
close-packed sheet in the case of N3P3[N(Me)NH2]6. When one of
the phosphorus atoms is substituted with a 2,2’-biphenol group
– spiro-N3P3[O2C12H8][N(Me)NH2]4 – it results in the formation of
a double chain through the hydrogen bonding of a ring nitrogen
atom to a N(Me)NH2 substituent. This is one of the few examples
of using tailored intermolecular interactions to direct the aggre-
gation of cyclotriphosphazenes.
There are also a number of known co-crystals containing a
cyclotriphosphazene derivative.10 One of the most interesting
co-crystals is that of hexakis(4-carboxyphenoxy)-cyclo-
triphosphazene with hexakis(4-pyridylcarbinoxy)cyclo-
triphosphazene (CSD refcode EZEJEY).11,12 Hydrogen bonds are
formed between the carboxylic acid and pyridyl groups on the
cyclotriphosphazenes. Due to the three-up and three-down
arrangement of the substituents on each cyclotriphosphazene,
they assemble to form columns in the crystal structure. Halogen
bonding between iodo-substituted perfluorocarbons and
pyridyl moieties has been successfully used to construct
co-crystals of cyclotriphosphazenes.10a,b One of these co-crystals
also forms a pillared structure due to the arrangement of the
cyclotriphosphazene substituents.10b These co-crystals served as
the inspiration to design similar pillared assemblies with differ-
ent cyclotriphosphazene derivatives.
We selected a number of substituted cyclotriphosphazenes
(Scheme 1) that have either the potential to form strong supra-
molecular synthons (hydrogen or halogen bonds), or have
awkward shapes, or both. We hoped that the flexibility and
awkward shape of these molecules in general might predispose
them to crystallize as solvates in the solid state. The co-formers
that were selected had the potential to form known supramo-
lecular synthons with the functional groups on the phosphazenes
(hydrogen bonds, halogen bonds, p–p interactions).
At the start of this investigation, it was anticipated that several
co-crystals would be obtained. Molecules and co-crystal formers
with the potential to form strong supramolecular synthons were
selected, and a thorough screen was planned. In general, publi-
cations involving co-crystal synthesis do not report problems
encountered in obtaining co-crystals. A close look at the most
recent papers in a top crystal engineering journal13 containing
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the word co-crystal (or cocrystal) in the title confirms this. One of
the studies discusses salt versus co-crystal formation, and it
appears multi-component crystals were obtained for all combi-
nations investigated.13c Four of the studies involve co-crystal
screens. In one screen it seems all combinations tried gave
co-crystals.13a In the other three screens, co-formers were chosen
so as to form strong intermolecular interactions. Two screens
had low rates of co-crystal formation (1 co-crystal from 8 combi-
nations13b and 4 co-crystals from 25 combinations13e), but make
no comment on this. The third screen found 4 co-crystals from
around 300 crystallizations.13d The researchers comment ‘The
scarcity of co-crystals of fenamic acid derivatives, as reported in
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Scheme 1
The cyclotriphosphazene derivatives investigated in this study.
this study and in previous literature, is due to both the strong
carboxylic acid homodimer synthon that is dominant within the
numerous polymorphs of the fenamic acid derivatives, and the
ability for the molecules to adopt several stable conformations of
their own. The strength of these interactions within these
systems results in the evident preferential formation of poly-
morphs over co-crystals.’
Some groups have reported investigations into why certain
co-crystals (or groups of co-crystals) do not readily form; how-
ever, these papers are few and far between.14 From the literature,
a newcomer to this field might expect that obtaining a co-crystal
is a relatively simple matter – as long as an appropriately strong
interaction could form between the two co-crystal formers, a
co-crystal will be isolated. The results of our extensive study,
reported herein, show that this is most certainly not always the
case.
2. Experimental
Cyclophosphazenes 1–12 were synthesized using established
literature procedures, with some adaptations where necessary.
Full details are given in the Supplementary material.
Almost 300 co-crystallization experiments were carried out in
this study. Details of these experiments are also given in full in
the Supplementary material. The choice of co-former was based
on the potential to form strong supramolecular synthons. For
example, phosphazenes containing pyridyl substituents were
co-crystallized with molecules containing carboxylic acids or
hydroxyl groups, in the hope that formation of a pyridyl...HO
hydrogen bond would drive co-crystal formation. We also inves-
tigated co-formers that might form p–p interactions or halogen
bonds. Finally, bulky or awkwardly-shaped molecules were also
investigated as co-formers. For lists of co-crystal formers and
solvates used, see Tables S1–S17 in the Supplementary material.
Very few mechanochemical experiments were carried out, as
this tended to result in degradation of the phosphazene ring,
most likely forming phosphazene polymers. There were no
issues with solubility of the phosphazenes used.
For the structures of 1, 5, and 10–12, X-ray intensity data were
collected on a Bruker-Nonius SMART Apex diffractometer
equipped with a fine-focus sealed tube and a 0.5 mm Monocap
collimator (monochromated Mo-Ka radiation, l = 0.71073 Å).
Data were captured with a CCD area-detector with the generator
powered at 40 kV and 30 mA. The temperature of the crystal was
controlled by constant stream of nitrogen gas produced by an
Oxford Cryosystems Cryostat (700 Series Cryostream Plus). For
the crystal structures of 6 and the co-crystal 7TPA, intensity
data were collected on a Bruker Apex DUO CCD diffractometer
with a multilayer monochromator. Mo-Ka radiation (l= 0.71073 Å)
was selected for the experiments. The temperature of the crystal
was controlled using an Oxford Cryosystems Cryostream. Data
reduction was done by means of a standard procedure using the
Bruker software package SAINT15 and the absorption corrections
and the correction of other systematic errors were performed
using SADABS.16 The structures were solved by direct methods
using SHELXS-97 and refined using SHELXL-97 and SHELXL-
2014/7.17 X-Seed18 was used as the graphical interface for the
SHELX program suite. Most hydrogen atoms were placed in
calculated positions using riding models. Hydrogen atoms on
nitrogen or oxygen atoms were located in the electron density
difference map and allowed to refine.
Cambridge Structural Database12 (CSD) searches were carried
out using ConQuest19 version 1.17 on version 5.36 with 3 updates
(Nov. 2014, Feb. 2015, May 2015).
For powder X-ray diffraction analysis, samples were ground to
a fine powder with a mortar and pestle and placed on a zero-
background sample holder. Experiments were carried out on a
PANalytical X’Pert PRO instrument in Bragg-Brentano geometry.
Intensity data were collected using an X’Celerator detector and
2q scans in the range of 5–50° were performed using Cu-Ka
radiation (l = 1.5418 Å).
Differential scanning calorimetry was carried out using a TA
Instruments Q100 system under an N2 gas purge, with a flow
rate of 50.0 ml min–1. The samples (ranging from 1.5 to 3 mg) were
placed in aluminium pans that were non-hermetically sealed
with vented aluminium lids. The heating rate for all experiments
was 10 °C min–1, and the cooling rate was 5 °C min–1.
3. Results and Discussion
3.1. CSD Analysis
In order to give some idea of the frequency with which
cyclotriphosphazenes form co-crystals or solvates, a Cambridge
Structural Database search was carried out.12 If the search is
restricted to ‘organic only’ structures with 3D co-ordinates
determined, 728 structures containing the cyclotriphosphazene
moiety are identified. Of these, 26 are salts or zwitterions (identi-
fied by searching for any charged atom). These were removed
(as salts are necessarily multi-component crystals). Of the remain-
ing 702 structures, only 109, or 15.5 %, are multi-component
crystals (>1 chemical residues). This is only slightly lower than
the occurrence in the CSD as a whole, where 16.8 % (42 601/252
827) of non-ionic organic structures are multi-component crystals.
These results imply that co-crystal or solvate formation is no
more or less likely to occur with cyclotriphosphazenes than with
any other molecule.
3.2. Co-crystallization Experiments
3.2.1. Co-crystallizations with 1
The choice of 1 as a potential co-crystal former was based on its
paddlewheel conformation, which indicated that it may form
inclusion compounds similar to those formed by TPP.3,4,5,6 The
NH-functional groups on 1 are also available as potential
hydrogen bond donors. A number of co-crystallization experi-
ments were carried out with 1 (Table S1). Only the crystallization
from THF/hexane yielded crystals. These proved to be the
known hydrate of 1 (CSD refcode COPVAE).20 We have
re-determined this structure at 173 K, and crystallographic data
are given in Table 1. El Murr et al.20 report the isolation of crystals
of non-solvated 1 from the reaction mixture, but these crystals
did not survive exposure to X-rays. However, the crystals grown
from methanol that incorporated water into the structure did
not disintegrate upon exposure to X-rays, suggesting that incor-
poration of water increases the stability of the crystal. It seemed
likely that other hydrogen bonding solvents might also fulfil this
role, and we therefore attempted crystallization from a number
of hydrogen bonding solvents (donors and acceptors, see
Table S1) in the hope of forming solvates. This was unsuccessful.
3.2.2. Co-crystallization Experiments with 2, 3 and 4
Numerous attempts to generate either solvates or co-crystals
with 2, 3 and 4 were made (see Tables S2, S4 and S6 in the Supple-
mentary material). None of these experiments yielded
multi-component crystals. In most cases either no crystals were
obtained, or crystals of the starting materials were obtained.
In order to investigate whether additional energy might be
required for co-crystal formation, mechanochemical experi-
ments were carried out with 2, 3 and 4. These derivatives were
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ground together with 4,4’-bipyridine, imidazole or benzimidazole
(Tables S3, S5, S7). The products obtained on grinding both 2 and
3 with imidazole were sticky white substances, whereas all the
other products were fine dry powders. The products of the
grinding experiments were analysed by PXRD, which showed
that all products consisted of physical mixtures of the reagents
(see Supplementary material).
The product obtained by grinding 2 with benzimidazole was
dissolved in THF. This yielded a pink precipitate with a powder
pattern that differs from those of both 2 and benzimidazole.
NMR analysis of this precipitate showed numerous signals in
the 31P spectrum that do not correspond with those normally
observed for 2. This could indicate that grinding the two compo-
nents together resulted in substitution of the chloro groups on
the cyclotriphosphazene ring, or that the cyclotriphosphazene
ring has opened and polymerized. The material is clearly not a
co-crystal of 2.
3.2.3. Crystal Structures of 5 and 6
Co-crystallization experiments were carried out with 5 in the
expectation that the awkward shape of the molecule might
cause inefficient packing in the solid state, resulting in inclusion
of solvent molecules. Attempts were therefore made to crystal-
lize 5 from a variety of solvents (Table S8). This yielded crystals of
5 in two cases (benzene and acetone). As the crystal structure of
this material has not previously been reported, it is described
here. Selected crystallographic data are given in Table 1.
Compound 5 crystallizes in the monoclinic space group P21/n.
One of the benzaldehyde groups is disordered over two positions
of approximately equal occupancy. The molecules form discrete
dimers via an offset face-to-face interaction between benzaldehyde
groups, and the dimers are arranged in chains with p-stacking
interactions between the biphenyl groups (Fig. 1). There are no
hydrogen bonds evident in the structure, confirming that the
aldehyde moiety is not a particularly strong hydrogen bond
acceptor. Despite this, 5 was co-crystallized with a wide range of
hydrogen bond donors. These co-crystallization experiments
are listed in Table S9 in the Supplementary material. The ratio of
5 to co-crystal former was 1:2 in most experiments in order to
take into account the two aldehyde moieties that could poten-
tially participate in hydrogen bonding interactions. None of
these experiments yielded any co-crystals. Some crystallizations
produced crystals of 5, some produced crystals of the co-formers
and some yielded no crystals at all.
Compound 6 was chosen for its potential to form supramo-
lecular synthons through the nitrile functionality. It is sparingly
soluble in most solvents, except for DMSO and DMF in which it
readily dissolves. Several co-crystallization experiments were
carried out with halogen-containing co-crystal formers (see
Table S10); however, no co-crystals were obtained. Rod-shaped
crystals of pure 6 were grown from a co-crystallization experi-
ment with bromopentafluorobenzene in DMSO. Selected crys-
tallographic details are given in Table 1.
Cyclophosphazene 6 crystallizes in P-1, with one molecule in
the asymmetric unit. Two cyanophenyl moieties are approxi-
mately parallel to one another above the plane of the phospha-
zene ring, and another two below the plane of the ring are also
approximately parallel to one another. The other two cyano-
phenyl moieties are twisted away from one another (Fig. 2a). The
molecules stack on top of one another to give columns parallel to
the crystallographic c axis (Fig. 2b). These columns pack along-
side one another in a slightly offset fashion. There are no imme-
diately apparent structure-directing intermolecular interactions
in this structure.
3.2.4. Co-crystallization Experiments with 7 and 8
Both 7 and 8 were chosen as possible co-crystal formers
because of the potential for hydrogen bond formation with
either the pyridyl or the hydroxyl functionality on the mole-
cules. One of the few known cyclotriphosphazene co-crystals
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Table 1 Selected crystal data for several cyclotriphosphazene derivatives.
1 5 6 7TPA 9á 21 10 11 12
Ratio 1:2 – – 1:2.5 – – – –
(phosphazene: other)
Chemical formula C9H28N9O2P3 C38H26N3O8P3 C42H24N9O6P3 C50H39N9O16P3 C36H24F6N3O6P3 C36H24Cl6N3O6P3 C36H24Br6N3O6P3 C36H24I6N3O6P3
Formula weight/ 387.31 745.53 843.61 1114.81 801.49 900.19 1166.95 1448.89
g mol–1
Crystal system Triclinic Monoclinic Triclinic Triclinic Monoclinic Monoclinic Orthorhombic Monoclinic
Space group P-1 P21/n P-1 P-1 P21/n P21/n Pnma P21/c
Z 4 4 2 2 4 4 4 4
a/Å 11.342(6) 10.897(2) 12.004(1) 7.943(4) 20.323(2) 17.642(1) 31.460(3) 13.472(1)
b/Å 11.374(6) 15.131(2) 12.315(1) 13.238(6) 8.051(8) 7.503(5) 13.367(1) 9.396(9)
c/Å 14.515(8) 20.907(3) 13.970(1) 23.627(1) 21.694(2) 27.914(2) 9.122(7) 32.635(3)
a/° 76.12(1) 90 80.628(2) 76.504(1) 90 90 90 90
b/° 76.43(1) 103.440(2) 80.015(2) 80.357(1) 103.831(1) 91.899(1) 90 96.230(1)
g/° 86.69(1) 90 71.023(1) 85.375(1) 90 90 90 90
Calculated 1.456 1.477 1.466 1.556 1.545 1.619 2.021 2.343
density/g cm–3
Cell volume/Å 3 1767.2(2) 3352.8(9) 1910.8(3) 2379.5(2) 3446.6(6) 3692.7(4) 3836.1(5) 4106.7(7)
Temperature/K 173(2) 100(2) 100(2) 100(2) 100(2) 103(2) 173(2) 100(2)
µ/mm–1 0.360 0.239 0.220 0.212 0.258 0.648 6.456 4.704
Independent 7360 3978 10363 11875 8117 6518 3514 7268
reflections
Rint 0.0153 0.0519 0.0454 0.0325 0.0290 0.0239 0.0550 0.0235
R1 [I > 2(I)] 0.0366 0.0601 0.0402 0.0374 0.0344 0.0281 0.0299 0.0309
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Figure 2 Packing in 6. (a) Orientation of the cyanophenyl moieties in 6. (b) Columns of molecules formed in 6.
Figure 1 Packing in 5. (a) The benzaldehyde moieties form discrete dimers via an offset face-to-face interaction. The structure can be viewed as
though the dimers form chains as shown in (b), indicated by the blue dotted lines. This is viewed down the crystallographic a axis. The chains then
close-pack as shown in (c), with close contacts between the biphenyl-2,2’-diol groups.
not based on TPP contains hexakis(4-pyridylcarbinoxy)cyclo-
triphosphazene, which is closely related to 7 (although the 3-D
coordinates for this co-crystal structure are not in the CSD).
Compound 7 therefore seemed a particularly promising candi-
date for co-crystal formation.
Numerous co-crystallization experiments were carried out
with both 7 and 8 (Tables S11 and S12 in the Supplementary
material). No co-crystals containing 8 were isolated. However,
7 was found to form a co-crystal with terephthalic acid, 7TPA.
Crystallographic data are given in Table 1.
The crystals of 7TPA were grown from a 1:2 ratio of
7:terephthalic acid in a layered solution of chloroform and DMF.
Crystals of 7 were dissolved in chloroform and the terephthalic
acid in DMF. Care had to be taken to add the two solutions
together slowly as terephthalic acid is insoluble in chloroform
and precipitates out of solution when chloroform is added to
DMF. The co-crystal, which contains 2.5 terephthalic acid mole-
cules for every molecule of 7, crystallizes in P-1. No charge trans-
fer has taken place, i.e. both carboxylic acid groups of each
terephthalic acid molecule are protonated, and these form
hydrogen bonds with the pyridyl groups on the cyclotriphos-
phazene. Five of the six pyridyl groups on the cyclotriphos-
phazene ring are involved in hydrogen bonding with a
terephthalic acid molecule through a COOH···N interaction
with the hydroxyl group of the carboxylic acid. This results in an
infinite hydrogen-bonded chain (Fig. 3a). The terephthalic acid
molecules shown in orange in Fig. 3b link neighbouring chains
through hydrogen bonding to a pyridyl group in the next chain.
It seems likely that the hydrogen bonds between 7 and
terephthalic acid are strong interactions, driving the formation
of a co-crystal. It is surprising, however, that no other co-crystals
with di-acids were isolated with this derivative despite this
seemingly strong interaction. This could indicate that the correct
shape match is very important in forming co-crystals with
cyclotriphosphazenes.
3.2.5. Co-crystallization Experiments with 9–12
The hexakis(4-halophenoxy)cyclotriphosphazene derivatives
9–12 were synthesized in order to investigate whether
co-crystals could be formed using supramolecular synthons
involving halogens. These derivatives were co-crystallized with
a range of small molecules, including molecules containing
halogens, nitriles and nitrogen-containing heterocycles such as
pyridine. The solvent systems that were used include acetonitrile,
acetonitrile/DCM, DCM, THF, THF/methanol, chloroform,
chloroform/acetone and DMSO, as well as combinations of these
solvents (Tables S13–16). In each case the cyclotriphosphazene
derivative crystallized as the pure material, rather than co-
crystallizing with other small molecules.
The crystal structures of 9–12 were originally determined at room
temperature.20 Our previous observation of polymorphism in 921
led us to redetermine the structures at 100 K, and the data are
included here for completeness (see Table 1). On analysis of the
crystal structures of these derivatives, it is apparent that
hexakis(4-fluorophenoxy)cyclotriphosphazene (9) and hexa-
kis(4-chlorophenoxy)cyclotriphosphazene (10) are isostruc-
tural, and that hexakis(4-bromophenoxy)cyclotriphosphazene
(11) and hexakis(4-iodophenoxy)cyclotriphosphazene (12) are
isostructural. The only differences between the structures are
slight changes in the twist of the phenoxy rings between deriva-
tives. DSC was also carried out on 9–12, but only 9 showed any
evidence of polymorphism in the temperature range investi-
gated.
The isostructurality between 9 and 10, as well as 11 and 12,
implied that combinations of these molecules may lead to
co-crystal formation. Unfortunately, co-crystals of 9 with 10, or
11 with 12, could not be grown from solution. The growth of
co-crystals by melting the isostructural compounds together
was then investigated (Table S17). Crystals of 9 and 10 were
ground together in a 1:1 ratio, melted and DSC analysis was per-
formed on the product. DSC analysis showed that the melting
point of the product (referred to as 9/10) is at 122.9 °C, which is
lower than the melting point of both 9 (129 °C) and 10 (152 °C).
The same procedure was followed for 11 and 12, and again there
is only one melting point at 173.1 °C. The melting point of 11 is
176.8 °C and that of 12 is 187.6 °C. This is, however, not conclusive
evidence that a co-crystal has formed.
PXRD analysis was carried out on the melt products 9/10 and
11/12. The results are shown in Fig. 4. PXRD analysis is unfortu-
nately also not conclusive. In both cases, the powder patterns of
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Figure 3 (a) The infinite hydrogen-bonded chain formed in 7TPA. (b) The hydrogen-bonded chains are linked via a terephthalic acid molecule,
shown here in orange, that hydrogen bonds to the pyridyloxy group of a neighbouring cyclotriphosphazene molecule.
the melt products largely correspond to the simulated patterns of
the halophenoxy derivatives. There are minor differences
between the patterns, but it is difficult to determine whether a
novel co-crystal has in fact formed. It is likely that any co-crystals
formed would be isostructural to the co-crystal formers, and
hence have similar powder patterns. The melt products could
also be solid solutions, as opposed to stoichiometric co-crystals.
We are thus unable to state conclusively whether these deriva-
tives form co-crystals from the melt.
3.3. Lack of Co-crystal Formation
During this investigation, a total of nearly 300 co-crystal-
lization experiments were carried out using 12 different
cyclophosphazene derivatives and a number of crystallization
techniques, and only one co-crystal was obtained. Largely, the
crystals that were obtained were of the pure cyclotriphos-
phazene derivative, with only one derivative (1) crystallizing as
a hydrate and no derivatives crystallizing as solvates. This is a
remarkably low success rate – the CSD study indicates that
around 15 % of cyclotriphosphazene-containing structures are
multi-component crystals. Why then was our success rate so
low?
The most obvious explanation is that the supramolecular
synthons employed were simply not strong enough to promote
co-crystallization, i.e. the heteromeric interactions were not as
strong as the homomeric interactions. This may well have been
the case for many of the combinations that were attempted,
although in a number of the molecules selected there are no
obvious strong intermolecular interactions in the crystals of the
pure material. However, this does not explain why a co-crystal
could be formed between 7 and terephthalic acid, but not
between 7 and any other carboxylic acids, despite numerous
attempts.
Inspection of the pKa values of the acids used (Table 2)
22
indicates that this is not simply a case of acid strength (and by
extension hydrogen bond strength). There are clearly other
factors involved.
It does appear that the size and shape of the co-crystallization
agent plays a role. A study conducted by Anderson et al.23 found
that molecules that crystallize with Z’ > 1 are generally
small, awkwardly shaped molecules. They are also more
conformationally restricted, which might explain why the
cyclotriphosphazenes seldom co-crystallize with smaller mole-
cules: cyclotriphosphazenes are much larger molecules with
substituents that are more conformationally flexible. It has also
been suggested that polymorphic molecules make better
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Figure 4 (a) PXRD analysis of the melt product 9/10. The pattern of 9/10 corresponds with the patterns of 9 and 10 to a large extent, but the results are
not conclusive. (b) PXRD analysis of the melt product of 11/12.
co-crystal formers.24 We do not observe this: compound 9 is
highly polymorphic, with four known polymorphs, yet no
co-crystals of this molecule were isolated. In this case, the
conformational flexibility of the molecule results in it crystalliz-
ing in a number of ways – the molecule can solve the problem of
close-packing without the need for a co-former. In order to
improve the probability of obtaining co-crystals or solvates with
cyclotriphosphazenes, the substituents on the P-N ring should
be conformationally restricted (no flexible O linkage). Func-
tional groups on the substituents should be strong hydrogen
bond donors or acceptors, or strong halogen bond acceptors
(such as iodine where the acceptor strength has been increased
by fluorination).
This study aimed to isolate co-crystals from solution, in the
manner one might carry out a co-crystal screen for a pharmaceu-
tical molecule. The difficulty encountered in obtaining
co-crystals was not at all anticipated. It is possible that with
further detailed investigation, the particular conditions to form
co-crystals of these molecules could be identified. Several
avenues were pursued to try and explain the low success rate,
including analysis of what preferred co-crystal formers might
be. None of these offered any insight – in fact, all analysis indi-
cated that we should be able to form other co-crystals with 7. It is
particularly interesting that no further co-crystals between 7 and
carboxylic acids were obtained. No obvious explanation for this
can be identified.
4. Conclusions
An extensive investigation of co-crystal formation with 12
cyclotriphosphazene derivatives has been carried out. Around
300 co-crystallization experiments were carried out, but only
one co-crystal was obtained. These results clearly indicate that
many cyclotriphosphazenes have a very low tendency to form
co-crystals. There is no clear explanation for this, but it serves as a
caution: the formation of co-crystals is not necessarily trivial,
and certainly more investigation is needed to shed light on why
this is the case.
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